GraniteShares Advisors »

BioMarin Pharmaceutical shares owned by GraniteShares Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by GraniteShares Advisors from 13F filings

Historical chart of GraniteShares Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by GraniteShares Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by GraniteShares Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $420k 6.0k 70.29
2024-06-30 $585k 7.1k 82.33

More positions owned by GraniteShares Advisors

Microsoft Corp MSFT (MSFT)
Meta Platforms Meta (META)
Alphabet Inc-cl A Googl (GOOGL)
Blackstone Long-short Credit BGX (BGX)
Nuveen Credit Strategies Incom JQC (JQC)
Alexander's Alx (ALX)
Nuveen Float Rate JFR (JFR)
Ltc Properties LTC (LTC)
Blackrock Ltd Duration BLW (BLW)
First Trust Snr Fl Rt Inc Ii FCT (FCT)
Nuveen Taxable Municipal NBB (NBB)
Ares Capital Corp Arcc (ARCC)
Getty Realty Corp Gty (GTY)
Gaming And Leisure Propertie Glpi (GLPI)
Eaton Vance Float Rt Inc Tr Eft (EFT)

View all positions for GraniteShares Advisors

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Ameriprise Financial
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
venBio Select Advisor
Citadel Advisors
Deutsche Bank Aktiengesellschaft

View all funds holding BioMarin Pharmaceutical